FDA Grants IDE Approval for Almac Diagnostic Services' CDx f

Turning Point Therapeutics and Almac Diagnostic Services recently announced approval by the US Food and Drug Administration of an investigational device exemption for use of an Almac diagnostic assay to determine whether cancer patients are ......More>>

Curetis to Receive €6.5M in Financing

German molecular diagnostics firm Curetis said recently that it will receive €6.5 million ($7.3 million) in gross proceeds under two financing facilities.......More>>

NeoGenomics Prices $149M Public Offering of Common Stock

NeoGenomics said after the close of the market recently that it has priced its previously announced underwritten public offering of 7 million shares of its common stock at a public offering price of $21.25 per share.......More>>

Qiagen Q1 Revenues Grow 2 Percent

Qiagen reported after the close of the market recently that its first quarter revenues grew nearly 2 percent year over year as the firm fell short of analysts topline estimates but beat expectations on the bottom line. For the three months......More>>

PrediLife Partners With Institut Curie on Breast Cancer Risk

PrediLife said recently that it has signed on the Institut Curie to perform the genetic analysis portion of its MammoRisk breast cancer risk assay.......More>>

Thermo Fisher Scientific to Invest $50 Million in Bioproduct

On May 20, 2019, Thermo Fisher Scientific announced that it is investing more than $50 million into its global bioproduction capabilities. The expansion will provide additional capacity for manufacturing single-use bioprocess container (BPC)......More>>